Johnson & Johnson (JNJ)

May 30, 2025, 10:07 AM EDT - 1 day ago

Johnson & Johnson: Relative Stability In A Wild 2025 Stock Market

May 30, 2025, 8:04 AM EDT - 1 day ago

J&J CEO Joaquin Duato on cancer treatments, M&A outlook and 'most favored nation' policy

May 28, 2025, 4:43 PM EDT - 3 days ago

Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

May 28, 2025, 2:31 PM EDT - 3 days ago

Johnson & Johnson (JNJ) Presents at the Bernstein's 41st Annual Strategic Decisions Conference (Transcript)

May 27, 2025, 8:30 AM EDT - 4 days ago

Johnson & Johnson: Dividend King On Sale Yielding Over 3% And Undervalued

May 27, 2025, 5:39 AM EDT - 4 days ago

Johnson & Johnson: Raising My Price Target Amid Stable EPS Growth

May 26, 2025, 7:30 AM EDT - 5 days ago

No Rolex For Me - I'm Buying Dividends That Pay For Life

GD LOW MCD MDT TXN

May 23, 2025, 8:00 AM EDT - 8 days ago

FDA Panel Reiterates the Cancer Risks of Talc

May 21, 2025, 4:40 PM EDT - 10 days ago

Johnson & Johnson to Participate in the Bernstein's 41st Annual Strategic Decisions Conference

May 21, 2025, 9:00 AM EDT - 10 days ago

Forget About Dividend Yield, Do This Instead

AAPL BAC C COP CVX D DUK

May 20, 2025, 6:21 PM EDT - 11 days ago

U.S. FDA Oncologic Drugs Advisory Committee votes in favor of the benefit-risk profile of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for high-risk smoldering multiple myeloma

May 20, 2025, 3:10 PM EDT - 11 days ago

Johnson & Johnson (JNJ) RBC Capital Markets Global Healthcare Conference

May 20, 2025, 12:24 PM EDT - 11 days ago

Dean Omar Branham Shirley Recognized Twice Among ALM's 2024 Top 100 Verdicts

May 19, 2025, 3:25 PM EDT - 12 days ago

Moody's U.S. Debt Downgrade: Stocks Poised To Benefit

AAL AAPL CCL CUK F GM GOOG

May 18, 2025, 4:32 PM EDT - 13 days ago

Statement On $147M Verdict for AMDR Member Innovative Health Against Johnson & Johnson's Biosense Webster Medical Technology Unit

May 15, 2025, 5:48 PM EDT - 16 days ago

Nachawati Law Group Files New Ovarian Cancer Lawsuits Against Johnson & Johnson After Latest Bankruptcy Ploy Fails

May 14, 2025, 8:00 PM EDT - 17 days ago

Jim Cramer talks good companies getting pummeled by rising interest rates

ABBV BMY CL GM PEP PG

May 14, 2025, 4:40 PM EDT - 17 days ago

Johnson & Johnson to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

May 13, 2025, 2:51 PM EDT - 18 days ago

Johnson & Johnson (JNJ) BofA Securities 2025 Healthcare Conference Transcript

May 13, 2025, 11:18 AM EDT - 18 days ago

Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trump's Executive Order.

LLY PFE ABBV

May 12, 2025, 6:25 PM EDT - 19 days ago

50 Fortune World's Most Admired Companies (FWMAC): 24 "Safer", 1 Ideal Buy

FDX GS JWN KO LLY LOW MS

May 12, 2025, 3:54 PM EDT - 19 days ago

Trump wants to slash U.S. drug prices with 'most favored nation' policy – here's what to know

ABBV GSK LLY MRK NVO NVS PFE

May 12, 2025, 3:35 PM EDT - 19 days ago

Johnson & Johnson: For Those Who Want Some Immunity Against Tariff Changes

May 12, 2025, 2:39 PM EDT - 19 days ago

10 stocks for a high-tariff world

BNS CMS EPD IDA KMB OBDC PEP

May 12, 2025, 1:14 PM EDT - 19 days ago

Drugmakers are spared worst-case drug pricing scenario for now

ABBV LLY MRK PFE

May 12, 2025, 12:36 PM EDT - 19 days ago

Dr. Scott Gottlieb: What to expect from President Trump's executive order to lower drug prices

ABBV AMGN AZN GILD GSK LLY MRK

May 12, 2025, 12:30 PM EDT - 19 days ago

Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet

ABBV AMGN BIIB BMY GILD LLY MRK

May 12, 2025, 11:24 AM EDT - 19 days ago

Trump says executive order will slash the cost of prescription drugs

ABBV LLY MRK PFE

May 12, 2025, 10:47 AM EDT - 19 days ago

Trump Announces Executive Order to Lower Drug Prices

LLY PFE MRK

May 12, 2025, 9:24 AM EDT - 19 days ago

White House release details on executive order on drug prices: Here's what to know

LLY MRK PFE

May 12, 2025, 5:30 AM EDT - 20 days ago

Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices

ABBV AMGN AZN GSK LLY MRK NVO

May 11, 2025, 7:30 AM EDT - 20 days ago

Fortress Dividends: 2 Of The Best All-Weather Income Stocks Built To Last

PEP

May 9, 2025, 6:25 PM EDT - 22 days ago

Final Trade: SLV, JNJ, HYG, GOOGL

GOOG GOOGL SLV HYG

May 9, 2025, 4:51 PM EDT - 22 days ago

Pharma Worries Shift to Prices From Trade. Trump's Next Plan Could Sink Stocks.

NVO NVS SNY

May 9, 2025, 8:14 AM EDT - 22 days ago

J&J's skin disease drug meets main goal in late-stage study

May 9, 2025, 8:05 AM EDT - 22 days ago

Icotrokinra results show significant skin clearance in patients with difficult-to-treat scalp and genital psoriasis

May 8, 2025, 7:23 PM EDT - 23 days ago

Pressure is still on the pharma sector, says Mizuho's Jared Holz

ABBV AMGN BMY GILD LLY MRK NVO

May 8, 2025, 12:07 PM EDT - 23 days ago

Jury Orders Johnson & Johnson to Pay $3 Million in Mesothelioma Death of New Orleans Woman

May 8, 2025, 8:12 AM EDT - 23 days ago

Johnson & Johnson expands efforts to champion the nursing workforce globally

May 8, 2025, 12:45 AM EDT - 24 days ago

Dividend Hikes Offer Optimism Amid Tariff Turmoil

HD LOW M NOBL NVDA PG ROST

May 6, 2025, 11:25 AM EDT - 25 days ago

3 Stable Stocks to Buy When the Price is Right

MSFT

May 5, 2025, 4:56 PM EDT - 26 days ago

Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms

ABBV LLY PFE

May 5, 2025, 8:05 AM EDT - 26 days ago

TREMFYA® (guselkumab) positioned to become the first and only IL-23 inhibitor to offer subcutaneous induction in ulcerative colitis as demonstrated in new data through 24 weeks

May 5, 2025, 8:05 AM EDT - 26 days ago

TREMFYA® (guselkumab) delivers sustained clinical and endoscopic remission in ulcerative colitis through two years

May 3, 2025, 9:46 AM EDT - 4 weeks ago

Dogs Of The Dow Chase May's 'Safer' Buy

AMGN AMZN BA CRM CSCO CVX DIS

May 2, 2025, 1:46 PM EDT - 4 weeks ago

Calls of the Day: AutoZone, Roblox, Eli Lilly, Johnson & Johnson and Quanta Services

AZO LLY PWR RBLX

May 2, 2025, 12:17 AM EDT - 4 weeks ago

J&J-backed HistoSonics explores sale at $2.5 billion valuation, FT reports

Apr 30, 2025, 4:12 PM EDT - 4 weeks ago

Healthy Returns: Here are the drugmakers with new U.S. investments as Trump's pharma tariffs loom

ABBV ABT DXCM GSK LLY MRK NVS

Apr 30, 2025, 1:42 PM EDT - 4 weeks ago

FDA Approves Johnson & Johnson's IMAAVYTM (nipocalimab-aahu) a New Treatment for Myasthenia Gravis (MG), Offering Hope for Families

Apr 30, 2025, 8:41 AM EDT - 4 weeks ago

US FDA approves J&J's immune disorder drug